Docetaxel plus trans-tracheal injection of adenoviral-mediated p53 versus docetaxel alone in patients with previously treated non-small-cell lung cancer

Cancer Gene Therapy

Volumn 18, Issue 6, 2011, Pages 444-449

  Ning, X ^a   Sun, Z ^a   Wang, Y ^a   Zhou, J ^a   Chen, S ^a   Chen, D ^b   Zhang, H ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

adenovirus vector; lung cancer; p53

Indexed keywords

DOCETAXEL; GENDICINE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RELAPSE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FEVER; FOLLOW UP; HEMOPTYSIS; HUMAN; INTRATRACHEAL DRUG ADMINISTRATION; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TRANSTRACHEAL DRUG ADMINISTRATION; TREATMENT RESPONSE;

ADENOVIRIDAE; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; HUMANS; INJECTIONS; LUNG NEOPLASMS; MIDDLE AGED; TAXOIDS; TRACHEA; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 79956138284     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2011.15     Document Type: Article

References (23)

1. Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemo-therapy. J Clin Oncol 2000; 18: 2095-2103. (Pubitemid 30324363)
2. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005; 353: 123-132. (Pubitemid 41058344)
3. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000; 92: 1764-1772.
4. Ahrendt SA, Hu Y, Buta M, McDermott MP, Benoit N, Yang SC et al. p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study. J Natl Cancer Inst 2003; 95: 961-970. (Pubitemid 36896713)
5. Tammemagi MC, McLaughlin JR, Bull SB. Meta-analyses of p53 tumor suppressor gene alterations and clinicopatho-logical features in resected lung cancers. Cancer Epidemiol Biomarkers Prev 1999; 8: 625.
6. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997; 89: 857.
7. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J et al. Molecular damage in bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997; 89: 1366.
8. Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol 1999; 187: 8.
9. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000; 92: 1764.
10. Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, Roth JA et al. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin Cancer Res 2001; 7: 2887-2897. (Pubitemid 32911399)
11. Nakamura Y, Futamura M, Kamino H, Yoshida K, Nakamura Y, Arakawa H. Identification of p53-46F as a super p53 with an enhanced ability to induce p53-dependent apoptosis. Cancer Sci 2006; 97: 633-641. (Pubitemid 44056612)
12. Ohtani S, Kagawa S, Tango Y, Umeoka T, Tokunaga N, Tsunemitsu Y et al. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo. Mol Cancer Ther 2004; 3: 93-100. (Pubitemid 39193682)
13. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA. Induction of chemosensitivity in human lung cancer in vivo by adenovirus-mediated transfer of the wildtype p53 gene. Cancer Res 1994; 54: 2287-2291. (Pubitemid 24138709)
14. Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH et al. Adenoviral-mediated p53 gene transfer in advanced non-small cell lung cancer. J Natl Cancer Inst 1999; 91: 763-771. (Pubitemid 29239055)
15. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997; 18: 857-862. (Pubitemid 27268450)
16. Moon C, Oh Y, Roth JA. Current status of gene therapy for lung cancer and head and neck cancer. Clin Cancer Res 2003; 9: 5055-5067. (Pubitemid 37413553)
17. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ et al. Retrovirus-mediated wildtype p53 gene transfer to tumors of patients with lung cancer. Nat Med 1996; 2: 985-991. (Pubitemid 26306836)
18. Sauthoff H, Heitner S, Rom WN, Hay JG. Deletion of the adenoviral E1B-19kD gene enhances tumor cell killing of a replicating adenoviral vector. Hum Gene Ther 2000; 11: 379-388. (Pubitemid 30101948)
19. Weill D, Mack M, Roth J, Swisher S, Proksch S, Merritt J et al. Adenoviral-Mediated p53 Gene Transfer to Non-small Cell Lung Cancer Through Endobronchial Injection. Chest 2000; 118: 966-970.
20. Schuler M, Rochlitz C, Horowitz JA, Schlegel J, Perruchoud AP, Kommoss F et al. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum Gene Ther 1998; 9: 2075-2082. (Pubitemid 28463925)
21. Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small cell lung cancer. J Clin Oncol 2000; 18: 609-622. (Pubitemid 30078542)
22. Zhang SW, Xiao SW, Liu CQ, Sun Y, Su X, Li DM et al. Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma. Zhonghua Zhong Liu Za Zhi 2005; 27: 426-428.
23. Schuler M, Herrmann R, De Greve JL, Stewart AK, Gatzemeier U, Stewart DJ et al. Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemother-apy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol 2001; 19: 1750-1758. (Pubitemid 32230877)